Contact
Diagnostics
About Abbott
i-STAT Registration
i-STAT Login
Customer Home
Partners Home
DISTRIBUTION HOME
Employees Home
REPAIR MANUAL
COMPLETE PROFILE
DASHBOARD
My Account
Worldwide

Global point of care

i-STAT in the ED | SEPSIS

ACCELERATE ANSWERS. ADVANCE CARE. BECAUSE EVERY MINUTE MATTERS, ASSESS SEPSIS RISK IN REAL-TIME WITH i-STAT LACTATE.

i-STAT in the ED | SEPSIS

ACCELERATE ANSWERS. ADVANCE CARE. BECAUSE EVERY MINUTE MATTERS, ASSESS SEPSIS
RISK IN REAL-TIME WITH i-STAT LACTATE.

i-STAT in the ED | SEPSIS

ACCELERATE ANSWERS. ADVANCE CARE. BECAUSE EVERY MINUTE
MATTERS, ASSESS SEPSIS RISK IN REAL-TIME WITH i-STAT LACTATE.

healthcare resources are strained

Complications such as sepsis can arise quickly in these patient populations. A patient stratification strategy including i-STAT can help you rapidy assess patients, quickly prioritize resources, and continue to deliver the highest quality care.

COMMON

Hospital admissions for sepsis have doubled over the past decade1

COSTLY

#1 inpatient cost in US hospitals, totaling >$27 billion/year2

CONSEQUENTIAL

Leading cause of US in-hospital mortality7

MEASURING LACTATE IS THE FIRST STEP IN THE HOUR-1 BUNDLE FROM THE SURVIVING SEPSIS CAMPAIGN.3

Every hour sepsis treatment is delayed, once the patient has developed hypotension, the risk of death increases by up to

8%4

“Patients who are ultimately found to be septic who get delayed treatment have a higher mortality. This data is overwhelming."

-Dr. Frank Peacock, Emergency Medicine

8%4

Every hour sepsis treatment is delayed, once the patient has developed hypotension, the risk of death increases by up to

“Patients who are ultimately found to be septic who get delayed treatment have a higher mortality. This data is overwhelming."

-Dr. Frank Peacock, Emergency Medicine

Solutions

WITH SEPSIS PATIENTS, EVERY MINUTE MATTERS

ACCELERATE SEPSIS RESPONSE IN YOUR ED WITH FAST, ACCURATE RESULTS AT THE POINT OF CARE USING i-STAT CG4+

cg4 cg4 cg4

LACTATE

RESULTS IN ~2 MIN

  • Evaluation of respiratory complications and determine the presence of hyperlactatemia to inform the risk stratification

i-STAT: RESULTS WITHIN MINUTES, RIGHT WITHIN THE CARE PATHWAY

ADVANTAGES ALIGNED TO YOUR ED PRIORITIES

  • Accelerating triage
  • Elevating the patient experience
  • Optimizing resource utilization
  • Standardizing workflows

AIDS ASSESSMENT OF ILLNESS SEVERITY

  • Help identify patients at higher risk of mortality, including those with septic shock
  • Eliminate the need for ice transport of samples
  • Reduce the risk of mislabeled/lost specimens


SEPSIS IS NOW INCLUDED IN BPCI, A BUNDLED PERFORMANCE-BASED PAYMENT MODEL6

  • In 2018, CMS added hospital sepsis performance data to its Hospital Compare web site5

THE VALUE of i-STAT lactate testing in the ED 

Testimonial Testimonial Testimonial

“It’s been game-changing for me… that lactate got ordered up in triage, ...to let you know who do we need to get fluids and antibiotics on early to drive an outcome.”

- Dr. Daniel Firestone, MD, ED Physician

SURVIVING SEPSIS CAMPAIGN HOUR-1 BUNDLE-LACTATE-GUIDED RESUSCITATION SIGNIFICANTLY REDUCES MORTALITY3

infographic

ACCELERATE ANSWERS. ADVANCE SEPSIS CARE

FIND OUT IF i-STAT IS THE RIGHT OPTION FOR YOUR ED

Learn More

References

  1. Advisory Board. 10 Imperatives to Reduce Sepsis Mortality. Advisory.com. Available at: https://www.advisory.com/research/physician-executive-council/studies/2014/ten-imperatives-to-reducesepsis.org/sepsis/definition/ [Accessed Sept. 7, 2018].
  2. Sepsis Alliance. Sepsis Definition. Sepsis.org Available at: https://www.sepsis.org/sepsis/definition/ [Accessed Sept. 7 2018].
  3. Levy MM, Evans LE, and Rhodes A. Intensive Care Med.
  4. Sepsis Alliance. Sepsis FAQ. Sepsis.org. Available at: www.beckershospitalreview.com/quality/hospital-compare-spotlights-hospitals-sepsis-performance.html [Accessed Sept. 7, 2018].
  5. Knowles M. Beckers hospitalreview.com. Available at:  
  6. CMS. BPCI Advanced. Innovation. Cms.gov. Available at: https://innovation.cms.gov/initiatives/bpci-advanced# [Accessed Sept. 7, 2018]
  7. Rudd et al, Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study, www.thelancet.com Vol 395 January 18, 2020

A Leader In Rapid Point-Of-Care Diagnostics.

PRODUCT CATALOG
SOLUTIONS
CUSTOMER STORIES
VIEWPOINTS
CONTACT US
PRODUCT DOCUMENT SEARCH
PRODUCT DEMOS
INTEREST-BASED ADS

©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy: US Citizens | Non-US Citizens. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement

Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.

Abbott - A Leader in Rapid Point-of-Care Diagnostics.